Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids.

× No keyword cloud information.

17 in total

Review 1. Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.

Authors: H L Weiner
Journal: Proc Natl Acad Sci U S A Date: 1999-03-30 Impact factor: 11.205

2. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.

Authors: R Aharoni; D Teitelbaum; R Arnon; M Sela
Journal: Proc Natl Acad Sci U S A Date: 1999-01-19 Impact factor: 11.205

3. Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1.

Authors: D Teitelbaum; R Aharoni; R Arnon; M Sela
Journal: Proc Natl Acad Sci U S A Date: 1988-12 Impact factor: 11.205

4. Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregation.

Authors: Jimmy Y Song; Nicholas R Larson; Sharadvi Thati; Irma Torres-Vazquez; Noraida Martinez-Rivera; Natalia J Subelzu; Martin A Leon; Eduardo Rosa-Molinar; Christian Schöneich; M Laird Forrest; C Russell Middaugh; Cory J Berkland
Journal: J Control Release Date: 2018-11-07 Impact factor: 9.776

Review 5. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis.

Authors: R Arnon; M Sela; D Teitelbaum
Journal: J Neurol Date: 1996-04 Impact factor: 4.849

6. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis.

Authors: R Aharoni; D Teitelbaum; M Sela; R Arnon
Journal: Proc Natl Acad Sci U S A Date: 1997-09-30 Impact factor: 11.205

7. Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1.

Authors: D Teitelbaum; R Aharoni; M Sela; R Arnon
Journal: Proc Natl Acad Sci U S A Date: 1991-11-01 Impact factor: 11.205

Review 8. Mechanism of action of glatiramer acetate in treatment of multiple sclerosis.

Authors: Martin S Weber; Reinhard Hohlfeld; Scott S Zamvil
Journal: Neurotherapeutics Date: 2007-10 Impact factor: 7.620

9. Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein.

Authors: D Teitelbaum; R Milo; R Arnon; M Sela
Journal: Proc Natl Acad Sci U S A Date: 1992-01-01 Impact factor: 11.205

10. Suppression and treatment of experimental allergic encephalitis in guinea-pigs with the bovine spinal cord protein (BSCP).

Authors: C F MacPherson
Journal: Immunology Date: 1980-07 Impact factor: 7.397